welcome
Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Health

Health

Why Akero Therapeutics (AKRO) Is Among the Best Performing Healthcare Stocks to Buy Now

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
Summary
Nutrition label

77% Informative

Akero Therapeutics, Inc. (NASDAQ: AKRO ) is a clinical-stage company that develops transformational treatments for patients with serious metabolic diseases that have high unmet medical needs.

The company’s primary product is efruxifermin ( EFX ), which treats MASH and is undergoing phase 3 of clinical trials.

Efruxifermin ranks 6th on our list of the best performing healthcare stocks to buy now.

AKRO ranks in the best-performing healthcare stocks in the world.

We acknowledge the potential for AKRO as an investment, but our conviction lies in the belief that some AI stocks hold greater promise.